What is the appropriate dose of Myospaz (paracetamol 500 mg/chlorzoxazone 250 mg) for children with muscle spasm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Myospaz Tablet Dosing in Children for Muscle Spasm

Myospaz (paracetamol 500 mg/chlorzoxazone 250 mg) is not recommended for use in children, as chlorzoxazone lacks established pediatric dosing guidelines and safety data, and the fixed-dose combination contains adult-strength paracetamol that exceeds safe pediatric dosing.

Why This Combination is Problematic in Children

Lack of Pediatric Evidence for Chlorzoxazone

  • Chlorzoxazone has no established pediatric dosing recommendations in major guidelines 1.
  • Muscle relaxants like chlorzoxazone, methocarbamol, and carisoprodol do not directly relax skeletal muscle and have no evidence of efficacy in chronic pain 1, 2.
  • All muscle relaxant trials were conducted for 2 weeks or less, indicating these agents should only be used short-term in adults 2.
  • Insufficient evidence exists for chronic use of any muscle relaxant for musculoskeletal pain 2.

Paracetamol Dosing Concerns

  • The 500 mg paracetamol component in Myospaz is an adult dose that would result in dangerous overdosing in children.
  • For a 20 kg child, the appropriate paracetamol dose would be 200-300 mg per dose (10-15 mg/kg), not 500 mg 1.
  • Administering 500 mg to a child weighing less than 33 kg would exceed the maximum safe dose of 15 mg/kg per dose.

Alternative Approaches for Pediatric Muscle Spasm

First-Line Management

  • For acute musculoskeletal pain in children, paracetamol alone at 10-15 mg/kg per dose (maximum 300 mg for children under 20 kg) is the appropriate initial therapy 1.
  • Ibuprofen can be considered as an alternative NSAID for pain relief 3.

When Muscle Relaxants Are Considered

  • If a muscle relaxant is truly indicated (which is rare in children), benzodiazepines or baclofen may be considered for actual muscle spasm 1, 2.
  • Benzodiazepines like diazepam have known pediatric dosing: 0.05-0.10 mg/kg IV for sedation/anxiolysis (maximum single dose: 5 mg) 1.
  • Baclofen is not recommended for routine musculoskeletal pain, as it is primarily an antispasticity agent for upper motor neuron syndromes 1, 2.

Critical Distinction: True Spasm vs. Pain

  • Most "muscle spasm" in children is actually musculoskeletal pain, not true spasm requiring muscle relaxants 1, 2.
  • Muscle relaxants should not be prescribed in the mistaken belief that they relieve muscle spasm, as their effects are nonspecific and not related to actual muscle relaxation 1.
  • If true muscle spasm from central nervous system injury or neuromuscular disorders is suspected, baclofen with careful dose titration may be appropriate 1.

Common Pitfalls to Avoid

  • Never use adult fixed-dose combinations in children - the component doses are inappropriate for pediatric weight-based dosing.
  • Do not assume "muscle spasm" requires a muscle relaxant - most cases respond to simple analgesics like paracetamol 1, 2.
  • Avoid chlorzoxazone in children entirely due to lack of safety and efficacy data in this population 1.
  • All muscle relaxants carry significant adverse effect risks including sedation, falls, and anticholinergic effects 1, 2.

Practical Recommendation

For a child with muscle spasm, prescribe paracetamol 10-15 mg/kg per dose (maximum 300 mg for children, 1 g for adolescents) every 4-6 hours as needed, rather than Myospaz tablets 1. If symptoms persist despite adequate analgesia, reassess for underlying pathology rather than adding a muscle relaxant.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Muscle Relaxant Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the uses of chlorzoxazone and thiocholchicoside?
What sleep medication is recommended for a 34-year-old male currently taking cyclobenzaprine (Flexeril)?
Can I add a muscle relaxer, such as cyclobenzaprine, to the treatment regimen of a 50-year-old male with post-operative jaw and mouth pain, swelling, and difficulty opening his mouth after a dental biopsy, who is already on antibiotics and pain medication?
What is the best course of treatment for a 61-year-old female patient with left-sided sciatica, presenting with severe left gluteal and hip pain radiating to the mid-thigh, despite minimal relief from Tylenol (acetaminophen) and cyclobenzaprine (Flexeril)?
What is the recommended oral dose of Cyclopam (cyclobenzaprine)?
What viral and fungal prophylaxis should be given to an adult with Acquired Immunodeficiency Syndrome and a CD4 T‑lymphocyte count less than 200 cells per microliter?
What is the recommended medical abortion regimen, including medication types, doses, routes of administration, timing, follow‑up, and contraindications, for a woman with an intra‑uterine pregnancy of ≤9 weeks gestation in India?
In an older adult with measurable memory and cognitive deficits who can still perform most instrumental activities of daily living independently, what is the appropriate term for this early-stage Alzheimer disease presentation?
A 47‑year‑old obese man (BMI ≈ 32 kg/m²) with mild obstructive sleep apnea presents with intermittent nocturnal gastroesophageal reflux disease causing substernal burning, laryngeal irritation, sensation of airway closure and brief dyspnea that awakens him, relieved only by large amounts of antacid; he has a high‑fat diet, consumes carbonated diet cola and occasional alcohol. What is the appropriate initial management plan for his gastroesophageal reflux disease, including pharmacologic therapy, lifestyle and dietary modifications, sleep‑apnea optimization, follow‑up, and key patient education points?
In a patient with chronic obstructive pulmonary disease (COPD) exacerbation on BiPAP, the arterial blood gas (ABG) shows pH 7.43, partial pressure of carbon dioxide (PaCO2) 59 mm Hg, partial pressure of oxygen (PaO2) 75 mm Hg, bicarbonate (HCO3-) 38.9 mmol/L; how should I interpret these results and adjust BiPAP settings and supplemental oxygen?
According to the National AIDS Control Organization (NACO), what are the recommended HIV testing protocol, first‑line antiretroviral therapy regimen (tenofovir + lamivudine + dolutegravir), baseline investigations, prophylaxis measures, viral load monitoring schedule, and criteria for switching to second‑line therapy in an adult patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.